Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study-Reference-Cited by-同舟云学术

Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study

Published:2021-04-01 Issue:4 Volume:44 Page:478-484
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Hamano Hirofumi¹,Mitsuhashi Chisato²,Suzuki Yoshiko³,Zamami Yoshito¹²,Tsujinaka Kaito²,Okada Naoto²,Niimura Takahiro¹,Hayama Tatsuya⁴,Imai Toru⁴,Ishida Shunsuke²,Sakamoto Kumiko²,Goda Mitsuhiro²,Takechi Kenshi⁵,Yagi Kenta⁶,Chuma Masayuki⁶,Horinouchi Yuya⁷,Shinomiya Kazuaki⁷,Ikeda Yasumasa⁸,Kirino Yasushi²,Nakamura Toshimi²,Yanagawa Hiroaki⁶,Hamada Yasuhiro³,Ishizawa Keisuke¹²

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Institute of Biomedical Sciences, Tokushima University Graduate School

2. Department of Pharmacy, Tokushima University Hospital

3. Department of Therapeutic Nutrition, Institute of Biomedical Sciences, Tokushima University Graduate School

4. Department of Pharmacy, Nihon University Itabashi Hospital

5. Department of Drug Information Analysis, College of Pharmaceutical Sciences, Matsuyama University

6. Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital

7. Department of Pharmaceutical Care and Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Tokushima Bunri Universityy

8. Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/4/44_b20-00609/_pdf

Reference36 articles.

1. 1) Popovic M, Warr DG, Deangelis C, Tsao M, Chan KK, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E. Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials. Support. Care Cancer, 22, 1685–1697 (2014).

2. 2) Browning KN. Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology. Front. Neurosci, 9, 413 (2015).

3. 3) Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Marangolo M, Amadori D, Bella MA, Gramazio V, Donati D. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J. Clin. Oncol., 9, 675–678 (1991).

4. 4) Italian Group for Antiemetic Research. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N. Engl. J. Med., 332, 1–5 (1995).

5. 5) Stoltz R, Cyong JC, Shah A, Parisi S. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects. J. Clin. Pharmacol., 44, 520–531 (2004).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study;Journal of Clinical Medicine;2024-02-01

2. Body image and the level of stress in cervical cancer patients;Bali Medical Journal;2022-11-26

3. The efficacy of single dose palonosetron in highly emetogenic chemotherapy protocols compared to oral aprepitant and ondansetron;Journal of Pharmacovigilance and Drug Research;2022-09-01